{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:10:42Z","timestamp":1792203042394,"version":"4.4.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873042"],"award-info":[{"award-number":["81873042"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872494"],"award-info":[{"award-number":["81872494"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803633"],"award-info":[{"award-number":["81803633"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Skeletal muscle atrophy is an important feature of cancer cachexia, which can be induced by chemotherapy, and affects the survival and quality of life of cancer patients seriously. No specific drugs for cancer cachexia have been applied in clinical practice. This study explored the therapeutic effect of linalool (LIN) on cisplatin (DDP) induced skeletal muscle atrophy. <jats:italic>In vivo<\/jats:italic>, LIN can improve skeletal muscle weight loss, anorexia, muscle strength decline and other cachexia symptoms caused by cisplatin treatment in a Lewis lung cancer tumor bearing mouse model, and cause no adverse effects on the anti-tumour effect. LIN treatment decreased the expression of muscle RING-finger protein-1 (MuRF1) and Atrogin1(MAFbx) in muscle, and the activation of insulin-like growth factor-1 (IGF-1)\/protein kinase B (Akt)\/forkhead box O (FoxO) pathway was observed. <jats:italic>In vitro<\/jats:italic>, LIN alleviated DDP induced C2C12 myotube atrophy, and IGF-1 receptor inhibitor Picropodophyllin (PIC), which had no adverse effect on C2C12 myotube cells, could reverse the protective effect of LIN. These results indicate that LIN down-regulates the expression of Atrogin1 and MuRF1 through the IGF-1\/Akt\/FoxO pathway, alleviating DDP-induced muscle atrophy and improving cachexia symptoms. LIN has the potential to be developed as a drug against cancer cachexia.<\/jats:p>","DOI":"10.3389\/fphar.2020.598166","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T06:30:33Z","timestamp":1606717833000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Linalool Prevents Cisplatin Induced Muscle Atrophy by Regulating IGF-1\/Akt\/FoxO Pathway"],"prefix":"10.3389","volume":"11","author":[{"given":"Hong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyi","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xipeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,30]]},"reference":[{"key":"B5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/s0074-7742(09)85017-4","article-title":"Linalool attenuates allodynia in neuropathic pain induced by spinal nerve ligation in c57\/bl6 mice","volume":"85","author":"Berliocchi","year":"2009","journal-title":"Int. Rev. Neurobiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1556\/2060.2020.00020","article-title":"High-intensity interval training-induced hypertrophy in gastrocnemius muscle via improved IGF-I\/Akt\/FoxO and myostatin\/Smad signaling pathways in rats","volume":"107","author":"Biglari","year":"2020","journal-title":"Acta Physiol. Hung."},{"key":"B7","doi-asserted-by":"publisher","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","article-title":"Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1","volume":"307","author":"Bodine","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/1440-1681.12559","article-title":"Skeletal muscle regeneration in cancer cachexia","volume":"43","author":"Bossola","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/jcsm.12426","article-title":"Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol","volume":"10","author":"Brierley","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/jcsm.12023","article-title":"Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved","volume":"6","author":"Chen","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jep.2018.12.035","article-title":"Modified Sijunzi decoction can alleviate cisplatin-induced toxicity and prolong the survival time of cachectic mice by recovering muscle atrophy","volume":"233","author":"Chen","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.18388\/abp.2016_1438","article-title":"SIRT3-SOD2-ROS pathway is involved in linalool-induced glioma cell apoptotic death","volume":"64","author":"Cheng","year":"2017","journal-title":"Acta Biochim. Pol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1016\/j.biocel.2013.05.016","article-title":"Muscle type and fiber type specificity in muscle wasting","volume":"45","author":"Ciciliot","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.3390\/ijms21041242","article-title":"Cisplatin-induced skeletal muscle dysfunction: mechanisms and counteracting therapeutic strategies","volume":"21","author":"Conte","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/jcsm.12185","article-title":"Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia","volume":"8","author":"Conte","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/jcsm.12267","article-title":"Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer","volume":"9","author":"Daly","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.phrs.2015.05.010","article-title":"Skeletal muscle atrophy: potential therapeutic agents and their mechanisms of action","volume":"99","author":"Dutt","year":"2015","journal-title":"Pharmacol. Res."},{"key":"B23","first-page":"6523","article-title":"Curative cancer chemotherapy","volume":"45","author":"Frei","year":"1985","journal-title":"Canc. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"7344","DOI":"10.1158\/0008-5472.CAN-14-0057","article-title":"Myostatin gene inactivation prevents skeletal muscle wasting in cancer","volume":"74","author":"Gallot","year":"2014","journal-title":"Canc. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-019-0768-8","article-title":"Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK(+) T-cell lymphoma","volume":"12","author":"George","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.pan.2019.07.039","article-title":"Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer","volume":"19","author":"Griffin","year":"2019","journal-title":"Pancreatology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/jcsm.12524","article-title":"Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer","volume":"11","author":"Huang","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B28","doi-asserted-by":"publisher","first-page":"112075","DOI":"10.1016\/j.jep.2019.112075","article-title":"The concurrent treatment of Scutellaria baicalensis Georgi enhances the therapeutic efficacy of cisplatin but also attenuates chemotherapy-induced cachexia and acute kidney injury","volume":"243","author":"Huang","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/j.jss.2012.10.050","article-title":"Anti-inflammatory effects of linalool in RAW 264.7 macrophages and lipopolysaccharide-induced lung injury model","volume":"180","author":"Huo","year":"2013","journal-title":"J. Surg. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"9765","DOI":"10.3748\/wjg.v22.i44.9765","article-title":"Anticancer effect of linalool via cancer-specific hydroxyl radical generation in human colon cancer","volume":"22","author":"Iwasaki","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.biocel.2013.05.032","article-title":"Muscle wasting in cancer","volume":"45","author":"Johns","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"105706","DOI":"10.1016\/j.intimp.2019.105706","article-title":"Anti-inflammatory effects of linalool on ovalbumin-induced pulmonary inflammation","volume":"74","author":"Kim","year":"2019","journal-title":"Int. Immunopharm."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-8900-3_1","article-title":"Introduction to FOXO biology","volume":"1890","author":"Link","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1097\/cad.0000000000000117","article-title":"FOXO3a mediates the cytotoxic effects of cisplatin in lung cancer cells","volume":"25","author":"Liu","year":"2014","journal-title":"Anti Canc. Drugs"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.2217\/fon.13.276","article-title":"Protective effect of Panax ginseng in cisplatin-induced cachexia in rats","volume":"10","author":"Lobina","year":"2014","journal-title":"Future Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2018.07.010","article-title":"Platinum-induced muscle wasting in cancer chemotherapy: mechanisms and potential targets for therapeutic intervention","volume":"208","author":"Moreira-Pais","year":"2018","journal-title":"Life Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0169136","DOI":"10.1371\/journal.pone.0169136","article-title":"Prognostic impact of CT-quantified muscle and fat distribution before and after first-line-chemotherapy in lung cancer patients","volume":"12","author":"Nattenmuller","year":"2017","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s12272-016-0714-z","article-title":"Neuroprotective effects of (-)-linalool against oxygen-glucose deprivation-induced neuronal injury","volume":"39","author":"Park","year":"2016","journal-title":"Arch Pharm. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.colsurfb.2018.08.001","article-title":"Linalool bioactive properties and potential applicability in drug delivery systems","volume":"171","author":"Pereira","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B40","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3892\/or_00000051","article-title":"Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells","volume":"20","author":"Ravizza","year":"2008","journal-title":"Oncol. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.lfs.2018.03.006","article-title":"Linalool induces cell cycle arrest and apoptosis in HepG2 cells through oxidative stress generation and modulation of Ras\/MAPK and Akt\/mTOR pathways","volume":"199","author":"Rodenak-Kladniew","year":"2018","journal-title":"Life Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1007\/s00018-014-1689-x","article-title":"Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways","volume":"71","author":"Rodriguez","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"109295","DOI":"10.1016\/j.biopha.2019.109295","article-title":"Linalool attenuates oxidative stress and mitochondrial dysfunction mediated by glutamate and NMDA toxicity","volume":"118","author":"Sabogal-Gu\u00e1queta","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.taap.2014.05.001","article-title":"Mechanisms of cisplatin-induced muscle atrophy","volume":"278","author":"Sakai","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/s0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/s10147-019-01460-8","article-title":"Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A)","volume":"24","author":"Sasaki","year":"2019","journal-title":"Int. J. Clin. Oncol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1111\/febs.12253","article-title":"Mechanisms regulating skeletal muscle growth and atrophy","volume":"280","author":"Schiaffino","year":"2013","journal-title":"FEBS J."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1111\/febs.14502","article-title":"Muscle fiber type diversity revealed by anti-myosin heavy chain antibodies","volume":"285","author":"Schiaffino","year":"2018","journal-title":"FEBS J."},{"key":"B51","doi-asserted-by":"publisher","first-page":"13017","DOI":"10.1038\/s41598-017-13504-y","article-title":"Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia","volume":"7","author":"Sirago","year":"2017","journal-title":"Sci. Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.semcancer.2016.01.002","article-title":"F-BOX proteins in cancer cachexia and muscle wasting: emerging regulators and therapeutic opportunities","volume":"36","author":"Sukari","year":"2016","journal-title":"Semin. Canc. Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.gene.2018.01.051","article-title":"Role of Forkhead Box O (FOXO) transcription factor in aging and diseases","volume":"648","author":"Tia","year":"2018","journal-title":"Gene"},{"key":"B54","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/MCO.0b013e328360272d","article-title":"Mechanisms for fiber-type specificity of skeletal muscle atrophy","volume":"16","author":"Wang","year":"2013","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"B55","doi-asserted-by":"publisher","first-page":"C570","DOI":"10.1152\/ajpcell.00338.2013","article-title":"Mathematical modeling reveals modulation of both nuclear influx and efflux of Foxo1 by the IGF-I\/PI3K\/Akt pathway in skeletal muscle fibers","volume":"306","author":"Wimmer","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1534735419828832","DOI":"10.1177\/1534735419828832","article-title":"D-methionine ameliorates cisplatin-induced muscle atrophy via inhibition of muscle degradation pathway","volume":"18","author":"Wu","year":"2019","journal-title":"Integr. Canc. Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"H1565","DOI":"10.1152\/ajpheart.00146.2010","article-title":"IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression","volume":"298","author":"Yoshida","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.bbamcr.2011.03.010","article-title":"Akt, FoxO and regulation of apoptosis","volume":"1813","author":"Zhang","year":"2011","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.598166\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T17:30:24Z","timestamp":1608226224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.598166\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,30]]},"references-count":49,"alternative-id":["10.3389\/fphar.2020.598166"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.598166","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,30]]},"article-number":"598166"}}